Showing results (461-470 of 614) with videos related to
Sort By:
Pageof 62
British Journal of Clinical Pharmacology|January 1, 1989
Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitorsB Waeber, L Juillerat-Jeanneret, J F Aubert, et al.Schweizerische Medizinische Wochenschrift|December 6, 1986
[Effects of perfusion of human atrial natriuretic factor in normal volunteers]J Bidiville, G Waeber, J Nussberger, et al.Clinical and Experimental Pharmacology & Physiology|August 1, 1987
Influence of bradykinin on blood pressure regulation of spontaneously hypertensive rats maintained on different sodium intakesB Waeber, J F Aubert, J Nussberger, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1987
[Attenuation of the vasopressor effect of angiotensin II, vasopressin and alpha 1-adrenergic stimulation by bradykinin]J F Aubert, B Waeber, J Nussberger, et al.Hypertension (Dallas, Tex. : 1979)|June 1, 1994
Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact ratsE Delacrétaz, D Hayoz, M C Osterheld, et al.American Heart Journal|March 1, 1982
Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activityB Waeber, I Gavras, H R Brunner, et al.American Journal of Hypertension|April 1, 1991
Dose-response relationships following oral administration of DuP 753 to normal humansY Christen, B Waeber, J Nussberger, et al.Journal of Hypertension|December 1, 1995
Endothelial function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemiaA Zanchi, E Delacrétaz, V Taleb, et al.Schweizerische Medizinische Wochenschrift|November 4, 1978
[Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers]P Jaeger, H R Brunner, G A Turini, et al.Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitorH R Brunner, H Gavras, G A Turini, et al.Pageof 62